Articles with public access mandates - Jeffrey KrischerLearn more
Not available anywhere: 4
Risk factors for chemotherapy‐induced nausea in pediatric patients receiving highly emetogenic chemotherapy
LL Dupuis, RN Tamura, KM Kelly, JP Krischer, AM Langevin, L Chen, ...
Pediatric Blood & Cancer 66 (4), e27584, 2019
Mandates: US National Institutes of Health
Physical activity and the development of islet autoimmunity and type 1 diabetes in 5-to 15-year-old children followed in the TEDDY study
X Liu, SB Johnson, KF Lynch, K Cordan, R Pate, MD Butterworth, ...
Diabetes care 46 (7), 1409-1416, 2023
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
A self-administered stress management intervention for hispanic patients undergoing cancer chemotherapy
CXA Loi, TM Nesman, P Xu, TR Taylor, S McMillan, JP Krischer, VL Tyc, ...
Journal of Immigrant and Minority Health 19, 1121-1131, 2017
Mandates: US National Institutes of Health
A qualitative exploration of patient perspectives on psychosocial burdens and positive factors in adults with osteogenesis imperfecta
WC Rork, AG Hertz, AD Wiese, KM Kostick, D Nguyen, SC Schneider, ...
American Journal of Medical Genetics Part A 191 (9), 2267-2275, 2023
Mandates: US National Institutes of Health
Available somewhere: 277
Temporal development of the gut microbiome in early childhood from the TEDDY study
CJ Stewart, NJ Ajami, JL O’Brien, DS Hutchinson, DP Smith, MC Wong, ...
Nature 562 (7728), 583-588, 2018
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
FX McCormack, Y Inoue, J Moss, LG Singer, C Strange, K Nakata, ...
New England Journal of Medicine 364 (17), 1595-1606, 2011
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association
RA Insel, JL Dunne, MA Atkinson, JL Chiang, D Dabelea, PA Gottlieb, ...
Diabetes care 38 (10), 1964-1974, 2015
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
KC Herold, BN Bundy, SA Long, JA Bluestone, LA DiMeglio, MJ Dufort, ...
New England Journal of Medicine 381 (7), 603-613, 2019
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
The human gut microbiome in early-onset type 1 diabetes from the TEDDY study
T Vatanen, EA Franzosa, R Schwager, S Tripathi, TD Arthur, K Vehik, ...
Nature 562 (7728), 589-594, 2018
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9789), 412-419, 2011
Mandates: US National Institutes of Health
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan
Y Inoue, BC Trapnell, R Tazawa, T Arai, T Takada, N Hizawa, Y Kasahara, ...
American journal of respiratory and critical care medicine 177 (7), 752-762, 2008
Mandates: US National Institutes of Health
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
JP Krischer, KF Lynch, DA Schatz, J Ilonen, Å Lernmark, WA Hagopian, ...
Diabetologia 58, 980-987, 2015
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
Clinical research for rare disease: opportunities, challenges, and solutions
RC Griggs, M Batshaw, M Dunkle, R Gopal-Srivastava, E Kaye, J Krischer, ...
Molecular genetics and metabolism 96 (1), 20-26, 2009
Mandates: US National Institutes of Health
International cooperation to enable the diagnosis of all rare genetic diseases
KM Boycott, A Rath, JX Chong, T Hartley, FS Alkuraya, G Baynam, ...
The American Journal of Human Genetics 100 (5), 695-705, 2017
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
DK Wherrett, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9788), 319-327, 2011
Mandates: US National Institutes of Health
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 381 (9881), 1905-1915, 2013
Mandates: US National Institutes of Health
A randomized, double‐blind trial of abatacept (CTLA‐4Ig) for the treatment of giant cell arteritis
CA Langford, D Cuthbertson, SR Ytterberg, N Khalidi, PA Monach, ...
Arthritis & rheumatology 69 (4), 837-845, 2017
Mandates: US Department of Defense, US National Institutes of Health
Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial–Type 1
T Orban, JM Sosenko, D Cuthbertson, JP Krischer, JS Skyler, R Jackson, ...
Diabetes care 32 (12), 2269-2274, 2009
Mandates: US National Institutes of Health
Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes
M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ...
Diabetes care 43 (1), 5-12, 2020
Mandates: US National Institutes of Health, US Department of Veterans Affairs, UK …
B-lymphocyte depletion with rituximab and β-cell function: two-year results
MD Pescovitz, CJ Greenbaum, B Bundy, DJ Becker, SE Gitelman, ...
Diabetes care 37 (2), 453-459, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program